Sample | Title | Value | Rank |
GSM958322 | U87-EV human glioblastoma xenograft - Control - 1 [HG-U133_Plus_2] | 10.4782 | 93 |
GSM958323 | U87-EV human glioblastoma xenograft - Control - 2 [HG-U133_Plus_2] | 10.2976 | 92 |
GSM958324 | U87-EV human glioblastoma xenograft - Control - 3 [HG-U133_Plus_2] | 10.0466 | 91 |
GSM958328 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 1 [HG-U133_Plus_2] | 10.4307 | 93 |
GSM958329 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 2 [HG-U133_Plus_2] | 10.0993 | 91 |
GSM958330 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 3 [HG-U133_Plus_2] | 10.0979 | 92 |
GSM958325 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 1 [HG-U133_Plus_2] | 10.0656 | 91 |
GSM958326 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 2 [HG-U133_Plus_2] | 10.0633 | 91 |
GSM958327 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 3 [HG-U133_Plus_2] | 10.1547 | 92 |